View in EDS

Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial.

Saved in:
Bibliographic Details
Title: Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial.
Authors: Kendall MA; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: kendall@sdac.harvard.edu., Hughes MD; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Kim S; Frontier Science Foundation, Brookline, MA, USA., Aaron LA; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Naini L; DLH Corporation, Bethesda, MD, USA., Suryavanshi N; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins Clinical Research Site, Pune, Maharashtra, India., Shah NS; Rollins School of Public Health, Emory University, Atlanta, GA, USA., Rouzier V; Les Centres Gheskio (Gheskio-INLR), Port-au-Prince, Haiti., Hafkin J; Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA., Sise T; Pharmaceutical Affairs Branch, Division of AIDS, National Institute of Allergy and Infectious Disease, Rockville, MD, USA., Beck J; Pharmaceutical Affairs Branch, Division of AIDS, National Institute of Allergy and Infectious Disease, Rockville, MD, USA., Heckman BE; Frontier Science Foundation, Amherst, NY, USA., Haberer JE; Center for Global Health, Massachusetts General Hospital, Boston, MA, USA., Harrington M; Treatment Action Group, New York, NY, USA., Scarsi KK; Antiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Hesseling AC; Faculty of Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa., Swindells S; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Churchyard GJ; Aurum Institute (NPC), Parktown, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA., Gupta A; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Source: Contemporary clinical trials [Contemp Clin Trials] 2025 Nov; Vol. 158, pp. 108084. Date of Electronic Publication: 2025 Sep 22.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40992540
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kendall+MA%22">Kendall MA</searchLink>; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: kendall@sdac.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Hughes+MD%22">Hughes MD</searchLink>; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+S%22">Kim S</searchLink>; Frontier Science Foundation, Brookline, MA, USA.<br /><searchLink fieldCode="AU" term="%22Aaron+LA%22">Aaron LA</searchLink>; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Naini+L%22">Naini L</searchLink>; DLH Corporation, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Suryavanshi+N%22">Suryavanshi N</searchLink>; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins Clinical Research Site, Pune, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Shah+NS%22">Shah NS</searchLink>; Rollins School of Public Health, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Rouzier+V%22">Rouzier V</searchLink>; Les Centres Gheskio (Gheskio-INLR), Port-au-Prince, Haiti.<br /><searchLink fieldCode="AU" term="%22Hafkin+J%22">Hafkin J</searchLink>; Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Sise+T%22">Sise T</searchLink>; Pharmaceutical Affairs Branch, Division of AIDS, National Institute of Allergy and Infectious Disease, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Beck+J%22">Beck J</searchLink>; Pharmaceutical Affairs Branch, Division of AIDS, National Institute of Allergy and Infectious Disease, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Heckman+BE%22">Heckman BE</searchLink>; Frontier Science Foundation, Amherst, NY, USA.<br /><searchLink fieldCode="AU" term="%22Haberer+JE%22">Haberer JE</searchLink>; Center for Global Health, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Harrington+M%22">Harrington M</searchLink>; Treatment Action Group, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Scarsi+KK%22">Scarsi KK</searchLink>; Antiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Hesseling+AC%22">Hesseling AC</searchLink>; Faculty of Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa.<br /><searchLink fieldCode="AU" term="%22Swindells+S%22">Swindells S</searchLink>; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Churchyard+GJ%22">Churchyard GJ</searchLink>; Aurum Institute (NPC), Parktown, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+A%22">Gupta A</searchLink>; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101242342%22">Contemporary clinical trials</searchLink> [Contemp Clin Trials] 2025 Nov; Vol. 158, pp. 108084. <i>Date of Electronic Publication: </i>2025 Sep 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial Protocol
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101242342 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-2030 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215517144%22">15517144 </searchLink><i>NLM ISO Abbreviation: </i>Contemp Clin Trials <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40992540
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cct.2025.108084
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108084
    Titles:
      – TitleFull: Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kendall MA
      – PersonEntity:
          Name:
            NameFull: Hughes MD
      – PersonEntity:
          Name:
            NameFull: Kim S
      – PersonEntity:
          Name:
            NameFull: Aaron LA
      – PersonEntity:
          Name:
            NameFull: Naini L
      – PersonEntity:
          Name:
            NameFull: Suryavanshi N
      – PersonEntity:
          Name:
            NameFull: Shah NS
      – PersonEntity:
          Name:
            NameFull: Rouzier V
      – PersonEntity:
          Name:
            NameFull: Hafkin J
      – PersonEntity:
          Name:
            NameFull: Sise T
      – PersonEntity:
          Name:
            NameFull: Beck J
      – PersonEntity:
          Name:
            NameFull: Heckman BE
      – PersonEntity:
          Name:
            NameFull: Haberer JE
      – PersonEntity:
          Name:
            NameFull: Harrington M
      – PersonEntity:
          Name:
            NameFull: Scarsi KK
      – PersonEntity:
          Name:
            NameFull: Hesseling AC
      – PersonEntity:
          Name:
            NameFull: Swindells S
      – PersonEntity:
          Name:
            NameFull: Churchyard GJ
      – PersonEntity:
          Name:
            NameFull: Gupta A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1559-2030
          Numbering:
            – Type: volume
              Value: 158
          Titles:
            – TitleFull: Contemporary clinical trials
              Type: main
ResultId 1